IRVING, Texas, Jan. 12, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision…
Financing led by institutional investors, with participation from new investor Eli Lilly and CompanyInclusive of this investment, a total of…
PITTSBURGH, Jan. 9, 2026 /PRNewswire/ -- Avista Therapeutics, a preclinical gene therapy company built on deep clinical, computational and gene…
Company unifies its AI ecosystem under doceree.ai, launches five industry-first AI solutions, earns top global recognitions, and defines the 2026…
Seasoned Silicon Valley founder and executive brings proven experience scaling advanced platforms through global commercialization and M&ARALEIGH, N.C., Jan. 8,…
Collaboration makes AI models trained on over $1 billion in Lilly research data accessibledirectly in scientists' workflowsSAN FRANCISCO, Jan. 8,…
Mississauga, Ontario--(Newsfile Corp. - January 7, 2026) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical…
New white paper details key technical milestones and validation of the company's proprietary, capsule-based platform to accelerate breakthroughs across human…
New white paper details key technical milestones and validation of the company's proprietary, capsule-based platform to accelerate breakthroughs across human…
New white paper details key technical milestones and validation of the company's proprietary, capsule-based platform to accelerate breakthroughs across human…